Receptor tyrosine-protein kinase erbB-2 (650-658)

Receptor tyrosine-protein kinase erbB-2 (650-658) is a synthetic peptide fragment corresponding to amino acid residues 650 through 658 of the human erbB-2 (HER2/neu) protein. As a well-characterized segment of the intracellular domain of this receptor tyrosine kinase, it plays a crucial role in studies of signal transduction, protein-protein interactions, and post-translational modification events. The sequence is highly relevant to the investigation of oncogenic signaling pathways, given erbB-2's established involvement in cellular growth, differentiation, and survival mechanisms. Researchers value this peptide for its utility in elucidating molecular mechanisms underlying receptor activation and downstream signaling cascades, making it a valuable reagent in the fields of molecular biology, biochemistry, and cancer research.

Epitope mapping: The 650-658 peptide fragment serves as a defined epitope for antibody generation and characterization. By providing a specific linear sequence from the intracellular region of the erbB-2 protein, it enables researchers to assess the specificity and binding affinity of monoclonal or polyclonal antibodies targeting the HER2/neu receptor. Such studies are vital for developing and validating immunodetection tools used in biochemical assays, immunoprecipitation, and Western blot applications.

Signal transduction research: The synthetic peptide is widely employed in dissecting the molecular mechanisms of HER2-mediated signaling. As a substrate or competitive inhibitor in kinase assays, it aids in the identification of phosphorylation sites and their regulatory roles in downstream pathways. Investigators utilize this fragment to probe the functional consequences of site-specific phosphorylation, facilitating a deeper understanding of how erbB-2 activation modulates cellular processes relevant to proliferation and differentiation.

Protein interaction studies: The 650-658 region of erbB-2 is implicated in mediating interactions with intracellular adaptor proteins and signaling effectors. Synthetic peptides corresponding to this sequence are instrumental in affinity purification, pull-down assays, and surface plasmon resonance experiments designed to identify and characterize binding partners. Such applications are fundamental in mapping signaling networks and uncovering novel regulatory mechanisms within the HER2/neu axis.

Peptide-based assay development: The defined sequence of this peptide enables its use as a standard or control in various biochemical assays, including enzyme-linked immunosorbent assays (ELISA) and mass spectrometry-based quantification. By incorporating the peptide into assay systems, researchers can calibrate detection sensitivity, evaluate assay linearity, and validate methodological reproducibility, ensuring robust and reliable experimental outcomes.

Structural and conformational analysis: The erbB-2 (650-658) peptide provides a model system for examining the structural properties of receptor intracellular domains. Through techniques such as nuclear magnetic resonance (NMR) spectroscopy and circular dichroism, scientists can investigate the conformational dynamics and secondary structure propensities of this segment. Insights gained from such studies contribute to a broader understanding of how local structural features influence receptor function and protein-protein interaction landscapes.

1. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling